Clinical Trial 43164

Los Angeles, CA 90024


Study STS101-002 is a randomized, double-blind, parallel group, placebo-controlled, multicenter study to evaluate the efficacy, safety, and tolerability of single doses of STS101 (dihydroergotamine nasal powder) in the acute treatment of migraine.

Key Inclusion Criteria:

  • Males or females
  • 18-65 years of age at the time of Screening Visit
  • Subject has at least 1-year history of migraines, with or without aura
  • Must have in-tact nasal passage

Qualified Participants May Receive:

Compensation of $100 for up to three (3) completed study visits up to three (3) months + compliance bonus for e-diary completion

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.